Advances in HIV therapeutics: the 14th CROI.
Boyle
Brian A
BA
Department of International Medicine and Infectious Diseases, New York Presbyterian Hospital-Weill Medical College of Cornell University, New York, USA.
Elion
Richard
R
Cohen
Calvin J
CJ
Moyle
Graeme J
GJ
Sax
Paul
P
Frank
Ian
I
D000212:Acyclovir / Q000627:therapeutic use; D019380:Anti-HIV Agents / Q000627:therapeutic use*; D002944:Circumcision, Male; D003510:Cyclohexanes / Q000009:adverse effects / Q000627:therapeutic use*; D015224:Dideoxynucleosides / Q000627:therapeutic use*; D004347:Drug Interactions; D005260:Female; D023581:HIV Fusion Inhibitors / Q000009:adverse effects / Q000627:therapeutic use*; D015658:HIV Infections / Q000150:complications / Q000188:drug therapy* / Q000517:prevention & control; D006526:Hepatitis C / Q000150:complications / Q000188:drug therapy; D006801:Humans; D008297:Male; D000077592:Maraviroc; D015337:Multicenter Studies as Topic; D009570:Nitriles; D009930:Organic Chemicals / Q000009:adverse effects / Q000627:therapeutic use*; D011724:Pyridazines / Q000009:adverse effects / Q000627:therapeutic use*; D011743:Pyrimidines; D011760:Pyrrolidinones; D000068898:Raltegravir Potassium; D016032:Randomized Controlled Trials as Topic; D014230:Triazoles / Q000009:adverse effects / Q000627:therapeutic use*; D000099227:Abacavir
D000212:Acyclovir; D019380:Anti-HIV Agents; D003510:Cyclohexanes; D015224:Dideoxynucleosides; D023581:HIV Fusion Inhibitors; D000077592:Maraviroc; D009570:Nitriles; D009930:Organic Chemicals; D011724:Pyridazines; D011743:Pyrimidines; D011760:Pyrrolidinones; D000068898:Raltegravir Potassium; D014230:Triazoles; D000099227:Abacavir; C451734:etravirine